ライフサイエンスコーパス: vesicular

1 ualized in brain sections stained for either vesicular acetylcholine transporter or choline acetyltra

2 n addition, dual localization of M2R and the vesicular acetylcholine transporter protein (VAChT), a m

3 The septal cells stained for vesicular acetylcholine transporter, but not for ChAT, h

4 dobenzovesamicol, a SPECT radiotracer of the vesicular acetylcholine transporter, to evaluate in vivo

5 we used brain sections immunostained for the vesicular acetylcholine transporter.

6 binding of (123)I-iodobenzovesamicol to the vesicular acetylcholine transporter.

7 e (ChAT) in stellate sympathetic neurons and vesicular ACh transporter immunoreactivity in tyrosine h

8 ized with protein gene product (PGP)9.5, the vesicular ACh transporter, and the high-affinity choline

9 ty was detected, partially colocalizing with vesicular amino acid transporter and GABA(A)-receptor ga

10 be involved in the control of Golgi membrane vesicular and lipid transport, we hypothesized that PKD

11 stribution in the cell is maintained by both vesicular and non-vesicular sterol transport.

12 after injury, and were contained both in the vesicular and nonvesicular fractions of plasma.

13 led by a combination of mechanisms involving vesicular and nonvesicular sterol transport processes.

14 distributed nonrandomly among membranes via vesicular and nonvesicular trafficking mechanisms.

15 d release of ACh from the endothelium is non-vesicular and occurs via organic cation transporters.

16 supernatant and serum are predominantly non-vesicular, and their release is independent of ceramide-

17 otic debris, exosomes or even release of non-vesicular antigen from infected cells.

18 with time from a micelle-like assembly to a vesicular assembly.

19 se transporter 1, claudin-3, and plasmalemma vesicular-associated protein have been identified as Wnt

20 2-generated PA and KIF5B is required for the vesicular association of KIF5B, surface localization of

21 their biogenesis within cells: mature multi-vesicular bodies fuse with the cellular membrane to libe

22 gradation and compounds contained within the vesicular bodies of the peanut increased after roasting.

23 or specific discrimination of VLPs from host vesicular bodies.

24 ocalization of HIV-1 with endosomal or multi vesicular body (MVB) markers such as CD81 and VPS4 and d

25 have identified synaptotagmin 10 (Syt10), a vesicular Ca(2+) sensor, as the first neuroprotective ef

26 uced transcriptional regulator NPAS4 and the vesicular Ca(2+)-sensor protein synaptotagmin 10 (Syt10)

27 -brain preparation, fluorescent reporters of vesicular cargo and of vesicular pH reveal that amphetam

28 s prevent unregulated fusion by sequestering vesicular cargo to MTs.

29 by promoting the biogenesis and transport of vesicular cargoes.

30 Vesicular cargos and organelles enter spines either by e

31 of motile activities, including transport of vesicular cargos, mRNAs, viruses, and proteins.

32 in one Golgi domain exit into predominantly vesicular carriers by interaction of sorting signals wit

33 These processes are mediated by tubular-vesicular carriers that bud from early endosomes and fus

34 Vesicular carriers transport proteins and lipids from on

35 encies into Golgi complex to plasma membrane vesicular carriers, and 2) the different deacylation rat

36 Glut4 and blocks their entry into the small vesicular carriers.

37 uring this time, the HPV genome remains in a vesicular compartment until the nucleus has completely r

38 ated with single viral particles in enclosed vesicular compartments or surface-localized virus partic

39 heterogeneous population of single-membraned vesicular compartments, which were decorated with compon

40 with lipoproteins, viral proteins, RNA, and vesicular components.

41 anced green fluorescent protein demonstrated vesicular cytosolic localization associated with the end

42 amentous material that would appear to limit vesicular diffusion.

43 ding herd that presented with an outbreak of vesicular disease (VD) that was associated with an incre

44 igation conducted in swine herds affected by vesicular disease and increased neonatal mortality.

45 ted with an increased number of outbreaks of vesicular disease and neonatal mortality in swine.

46 irus (FMDV) causes a highly contagious acute vesicular disease in cloven-hoofed livestock and wildlif

47 irus (FMDV) causes a highly contagious acute vesicular disease in domestic livestock and wildlife spe

48 Vesicular dynamic analysis shows the common spatio-tempo

49 into synaptic vesicles without promoting non-vesicular efflux across the plasma membrane.

50 on membrane potential, which would drive non-vesicular efflux, and the role of protons is unclear.

51 tosis field, and has been rarely studied for vesicular endocytosis in secretory cells.

52 the endoplasmic reticulum (ER), ranging from vesicular ER to markedly expanded cisternae with accumul

53 Blockade of vesicular exocytosis in preBotC astrocytes bilaterally (

54 late ATP release from the urothelium through vesicular exocytosis mechanisms with minimal contributio

55 mulating ATP release from the urothelium via vesicular exocytosis mechanisms with minimal contributio

56 eletion of Atf6alpha abrogated Thbs4-induced vesicular expansion.

57 polytriazolium poly(ionic liquid) (PIL) in a vesicular form in solution that allows for crafting a va

58 to determine whether a novel tumor-targeted vesicular formulation of tocotrienol would suppress the

59 these important cellular processes, such as vesicular fusion and trafficking, require calcium (Ca(2+

60 nsities of ChC cartridges immunoreactive for vesicular GABA transporter (vGAT+), which is present in

61 rojecting neurons in the LH that express the vesicular GABA transporter (VGAT; a marker for GABA-rele

62 TRN neurons through conditional deletion of vesicular GABA transporter has no effect on spontaneous

63 either by cell type-specific deletion of the vesicular GABA transporter or by expression of botulinum

64 analysis identified a selective reduction of vesicular GABA transporter punctae on parvalbumin positi

65 We saw that stimulation of vesicular gamma-aminobutyric acid (GABA) transporter (VG

66 , as indicated by expression of mRNA for the vesicular GLU transporter (vGluT).

67 injections or an antibody against the type 2 vesicular glutamate antibody (vGLUT2).

68 ibit what would otherwise be substantial non-vesicular glutamate efflux at the plasma membrane, there

69 t developed in virtually complete absence of vesicular glutamate release.

70 protons and chloride allosterically activate vesicular glutamate transport.

71 nsic H(+) /Na(+) exchange via the Drosophila vesicular glutamate transporter (DVGLUT).

72 ate is loaded into synaptic vesicles via the vesicular glutamate transporter (VGLUT), a mechanism con

73 nduced hyperacidification is mediated by the vesicular glutamate transporter (VGLUT).

74 notype based on coexpression of mRNA for the vesicular glutamate transporter (vGlut2) and the GABA sy

75 aled that most neurons in the GT express the vesicular glutamate transporter (VGluT2) mRNA, indicatin

76 er crushing the tibial nerve (TN), and using Vesicular GLUtamate Transporter 1 (VGLUT1) and the 65 kD

77 yrosine hydroxylase in periglomerular cells, vesicular glutamate transporter 1, a presynaptic protein

78 excitatory synapses, defined by overlapping vesicular glutamate transporter 1-positive (VGlut1+) and

79 ve excitatory synapses (i.e., the overlap of vesicular glutamate transporter 1-positive [VGlut1+] pun

80 gamma isoform, neurofilament light chain and vesicular glutamate transporter 1.

81 ic boutons by their immunoreactivity for the vesicular glutamate transporter 2 (VGluT2) and performed

82 BN and lPBN-->CeA CGRP projections coexpress vesicular glutamate transporter 2 (VGLUT2), providing ev

83 nd perisomatic rings of terminals expressing vesicular glutamate transporter 2 (VGLUT2)--to subdivide

84 so on VTA glutamatergic neurons that express vesicular glutamate transporter 2 (VgluT2).

85 d neuronal markers [neurofilament, NeuN, and vesicular glutamate transporter 2 (VGlut2)], and culture

86 ntermixed with glutamate neurons (expressing vesicular glutamate transporter 2; VGluT2), which play r

87 circuits of basket cells expressing CCK and vesicular glutamate transporter 3 (VGlut3).

88 DVGLUT functions not only as a vesicular glutamate transporter but also serves as an ac

89 he synaptic vesicle machinery, including the vesicular glutamate transporter eat-4/VGLUT, induction o

90 TATEMENT VGLUT3 is an atypical member of the vesicular glutamate transporter family.

91 Specifically, the vesicular glutamate transporter is upregulated, leading

92 The atypical vesicular glutamate transporter type 3 (VGLUT3) is expre

93 e were immunopositive for met-enkephalin and vesicular glutamate transporter VGLUT2, but not for GABA

94 we also performed antibody stainings against vesicular glutamate transporter-2, which suggested that

95 e (TH), glutamate decarboxylase (GAD67), and vesicular glutamate transporters (vGLUT1 and vGLUT2) in

96 burtoni using in situ hybridization to label vesicular glutamate transporters (vglut1, vglut2.1, vglu

97 ology to record currents associated with the vesicular glutamate transporters (VGLUTs), we characteri

98 By expressing vesicular glutamate transporters at high levels in plasm

99 ng stains for Nissl, cytochrome oxidase, and vesicular glutamate transporters, we investigated the pr

100 for Nissl substance, cytochrome oxidase, and vesicular glutamate transporters.

101 nstrated that these neurons also express the vesicular glutamate type 2 transporter and co-release do

102 esicle dopamine content prior to release via vesicular hyperacidification.

103 rphologies (spherical, cylindrical, worm, or vesicular) in equilibrium with each other.

104 2 (Chrna2) in mice to genetically target the vesicular inhibitory amino acid transporter (VIAAT) in R

105 s in the GLv showed strong expression of the vesicular inhibitory amino acid transporter (VIAAT) mRNA

106 GABA(A)-receptor subunit and the presynaptic vesicular inhibitory amino acid transporter protein show

107 ectrophysiological character is dependent on vesicular inhibitory amino acid transporter-mediated sig

108 days 1 to 5, and joint pain, joint swelling, vesicular lesions (blisters), and rashes from days 1 to

109 Notably, SVA was detected and isolated from vesicular lesions and tissues of affected pigs, environm

110 These networks are frequently infiltrated by vesicular lipid inclusions that may originate from the d

111 35 showed large vacuolar as well as punctate vesicular localization.

112 methods for building penetrated channels on vesicular membrane surface often involve regulating the

113 nzyme, is expressed on the plasma as well as vesicular membranes and critically influences metastatic

114 strong upon attachment of activated Rap1b to vesicular membranes that mimic the agonist-induced micro

115 (ERC) is a series of perinuclear tubular and vesicular membranes that regulates recycling to the plas

116 y, many virions were encapsulated within the vesicular membranes, with an obvious release stage obser

117 that acute pharmacological inhibition of the vesicular monoamine transporter (VMAT) blocks amphetamin

118 TH1-S31E associated with vesicular monoamine transporter 2 (VMAT2) and alpha-synu

119 We previously reported that the vesicular monoamine transporter 2 (VMAT2) is physically

120 scent false neurotransmitter 200 (FFN200), a vesicular monoamine transporter 2 (VMAT2) substrate that

121 th tracers for the serotonin transporter and vesicular monoamine transporter 2 (VMAT2).

122 ly smaller than the dopamine transporter and vesicular monoamine transporter 2 defects, suggesting up

123 ine (NBI-98854) is a novel, highly selective vesicular monoamine transporter 2 inhibitor that demonst

124 emission tomography (PET) radioligand to the vesicular monoamine transporter 2, (VMAT2), [(11)C]dihyd

125 Vesicular monoamine transporter type 2 (VMAT2) imaging w

126 y of fixed doses of deutetrabenazine-a novel vesicular monoamine transporter-2 inhibitor-in patients

127 pport for the role of Myo1c in intracellular vesicular movement of Neph1 and its turnover at the memb

128 f bicontinuous nanospheres, filomicelles and vesicular, multilamellar and tubular polymersomes from p

129 en applied for the fabrication of complex or vesicular nanoarchitectures capable of encapsulating hyd

130 ts with the fusion of vesicles into a tubulo-vesicular network [4-6].

131 oxin light chain expression, which prevented vesicular neurotransmitter release.

132 By comparing vesicular nucleotide transporter (VNUT)-deficient and wi

133 store antigens, raising the possibility that vesicular or transcellular pathways may be important in

134 phospholipids are thought to occur by a non-vesicular pathway at contact sites between two closely a

135 cytosol rather than transport via a specific vesicular pathway.

136 lar transporters to dynamically increase the vesicular pH gradient, thereby increasing dopamine vesic

137 orescent reporters of vesicular cargo and of vesicular pH reveal that amphetamine redistributes vesic

138 ss promotes colocalization of Plexin-D1 with vesicular pools of active R-ras, leading to its inactiva

139 presynaptic machinery responsible for these vesicular processes in vivo.

140 Evaluating autophagy as a measure of vesicular processing and maturation further revealed tha

141 nce and fission pore conductance, imaging of vesicular protein endocytosis, and electron microscopy.

142 rites, highlighting an unexpected role for a vesicular protein in the maturation of GnRH neuronal net

143 xpression levels of Dmxl2, which encodes the vesicular protein rabconnectin-3alpha, determine the cap

144 nal spheroids and contained mitochondria and vesicular proteins.

145 iatal synaptosomal mitochondria and synaptic vesicular proton pump protein (V-ATPase H) levels.

146 e from preexisting clusters, consistent with vesicular recruitment and receptor heterooligomerization

147 The majority of ribbon markers, presynaptic vesicular release and postsynaptic neurotransduction-rel

148 el model to predict the time distribution of vesicular release at neuronal synapses.

149 nnels, signaling proteins, neuropeptides and vesicular release components, and transcription factors.

150 , we describe procedures that allow reliable vesicular release counting at simple synapses between pa

151 PITPNC1-mediated vesicular release drives metastasis by increasing the se

152 Vesicular release is triggered by the binding of few cal

153 [Ca(2+)]i in spinal astrocytes, which causes vesicular release of ATP and activation of P2X7Rs to tri

154 We explored a working hypothesis that vesicular release of ATP by astrocytes in the pre-Botzin

155 To functionally assess COMT inactivation of vesicular release of DA we used fast-scan cyclic voltamm

156 ially employs COMT enzymatic inactivation of vesicular release of DA.

157 s on multiple factors, including presynaptic vesicular release of transmitter, postsynaptic receptor

158 cles, whereas the region II mutation reduced vesicular release probability.

159 A domain is critical for additional steps of vesicular release, including vesicle docking.

160 ich facilitates Golgi extension and enhanced vesicular release.

161 nsitivity to nifedipine, mainly regulate the vesicular replenishment of the RRP; that is, the sustain

162 by MCs into excitatory signals that trigger vesicular serotonin release from MCs.

163 ling between adjacent nanoparticles in their vesicular shell makes ultrasensitive biosensing and bioi

164 We demonstrate that the vesicular signaling lipid phosphatidylinositol bisphosph

165 assembly of SNARE complexes that include the vesicular SNARE, synaptobrevin 2, and that the participa

166 intact circuit, confirming the role of these vesicular SNAREs in setting synaptic strength.

167 Our studies reveal vesicular sorting mechanisms controlling the constitutiv

168 the mechanisms responsible for this complex vesicular sorting will be critical to understand VGLUT's

169 cell is maintained by both vesicular and non-vesicular sterol transport.

170 se surrogate systems such as the rhabdovirus vesicular stomatitis Indiana virus (VSV), lentiviruses o

171 onstrated clinical efficacy of a recombinant vesicular stomatitis virus (rVSV) vaccine vector has sti

172 Recombinant vesicular stomatitis virus (rVSV) was shown to be a high

173 tenuated, replication-competent, recombinant vesicular stomatitis virus (rVSV)-based vaccine candidat

174 The replication-competent recombinant vesicular stomatitis virus (rVSV)-based vaccine expressi

175 This study focuses on oncolytic vesicular stomatitis virus (VSV) against pancreatic duct

176 at intermediate pH for two vesiculoviruses, vesicular stomatitis virus (VSV) and Chandipura virus (C

177 nctional L protein of rhabdoviruses, such as vesicular stomatitis virus (VSV) and rabies virus, catal

178 The glycoproteins (G proteins) of vesicular stomatitis virus (VSV) and related rhabdovirus

179 d infections with enveloped viruses, such as Vesicular Stomatitis Virus (VSV) and Respiratory Syncyti

180 ectious autonomously replicating recombinant vesicular stomatitis virus (VSV) in which the glycoprote

181 Vesicular stomatitis virus (VSV) is a promising oncolyti

182 n direct cell-to-cell transmission of either vesicular stomatitis virus (VSV) or the retrovirus MoMLV

183 entry, 49 constructs were incorporated onto vesicular stomatitis virus (VSV) pseudoparticles and tra

184 stimulated genes within the brain.IMPORTANCE Vesicular stomatitis virus (VSV) shows considerable prom

185 s (MoMLV) spread, and only minimally affects vesicular stomatitis virus (VSV) spread, to adjacent cel

186 rements in a simplified system, we generated vesicular stomatitis virus (VSV) virions pseudotyped wit

187 We injected vesicular stomatitis virus (VSV), a transsynaptic tracer

188 K-deficient MEFs exhibit impaired control of vesicular stomatitis virus (VSV), a virus sensed by STIN

189 al infection with influenza A virus (IAV) or vesicular stomatitis virus (VSV), respectively.

190 RdRP with those of the related rhabdovirus, vesicular stomatitis virus (VSV), we demonstrate that bo

191 reporter strain of the negative-sense ssRNA vesicular stomatitis virus (VSV), we show that microinje

192 Recombinant vesicular stomatitis virus (VSV)-based chimeric viruses

193 Here, vesicular stomatitis virus (VSV)-based pseudovirions dis

194 In the vesicular stomatitis virus (VSV)-induced encephalitis mo

195 ue of Blood, Shen et al demonstrate that the vesicular stomatitis virus (VSV)-murine interferon beta

196 ite-directed mutagenesis of the L protein of vesicular stomatitis virus (VSV, a prototypic NNS RNA vi

197 n response to infection with the RNA viruses vesicular stomatitis virus and Sendai virus and to trans

198 Using a recombinant vesicular stomatitis virus containing LUJV GP as its sol

199 We generated a recombinant vesicular stomatitis virus encoding Ebola virus Makona v

200 ression plasmid followed by infection with a vesicular stomatitis virus expressing the Zaire ebolavir

201 these MAbs to protect from infection with a vesicular stomatitis virus expressing the Zaire ebolavir

202 ination with virus-like particles displaying vesicular stomatitis virus G protein, RNAdjuvant promote

203 gradation of SAMHD1 does not rescue HIV-1 or vesicular stomatitis virus G-pseudotyped lentivectors in

204 uction enhancement with LVs pseudotyped with vesicular stomatitis virus glycoproteins and also with m

205 defect early after Listeria monocytogenes or vesicular stomatitis virus infection but comparable cyto

206 with apoptotic triggers such as etoposide or vesicular stomatitis virus infection, but disassemble in

207 Using vesicular stomatitis virus pseudovirions bearing EBOV gl

208 ion conferred by an EBOV vaccine composed of vesicular stomatitis virus pseudovirions that lack nativ

209 ession of HAP2 on the surface of pseudotyped vesicular stomatitis virus results in homotypic virus-ce

210 lescents and 35% of children had recombinant vesicular stomatitis virus RNA detectable in saliva.

211 3 vaccine (ChAd3-EBO-Z) and the recombinant vesicular stomatitis virus vaccine (rVSVG-ZEBOV-GP) in L

212 d vaccinia virus Ankara, complex adenovirus, vesicular stomatitis virus, alphavirus-based chimeras, a

213 ction as an entry inhibitor for JUNV and for vesicular stomatitis virus, lymphocytic choriomeningitis

214 dary challenges with Listeria monocytogenes, vesicular stomatitis virus, or Vaccinia virus, but dispe

215 sponses than UV-inactivated cytomegalovirus, vesicular stomatitis virus, reovirus, or adenovirus.

216 EBOV is a recombinant, replication competent vesicular stomatitis virus-based candidate vaccine expre

217 2503202) evaluated the safety of recombinant vesicular stomatitis virus-Zaire Ebola virus envelope gl

218 safety and immunogenicity of the recombinant vesicular stomatitis virus-Zaire Ebola virus envelope gl

219 is observed after intranasal challenge with vesicular stomatitis virus.

220 PPRV were able to neutralize RPV-pseudotyped vesicular stomatitis virus.

221 including influenza A, Zika, Ebola, Sindbis, vesicular stomatitis, cowpox, and vaccinia, but not muri

222 IDLVs pseudotyped with different envelopes (vesicular stomatitis, Rabies, Mokola and Ross River vira

223 Moreover, vesicular stomatosis virus-induced IL-1beta secretion wa

224 ATP7B regulates vesicular storage of Cu in mouse intestine.

225 P focus at the tip near the Spitzenkorper, a vesicular structure involved in molecular trafficking to

226 tes of exposure followed by the formation of vesicular structures and internalization.

227 MNV and Norwalk virus (NV) induce prominent vesicular structures and that this formation is dependen

228 ermore, in transmission electron microscopy, vesicular structures are observed in connection with the

229 Our discovery about the assembly of novel vesicular structures could be of interest for stabilizat

230 scopy, we observed that the membrane-derived vesicular structures induced by MNV NS3 were highly moti

231 of podosomes, whereas ARF1 was localized to vesicular structures transiently contacting podosome rin

232 s fluorescent peptide is internalized within vesicular structures, including glycosomes, and can be v

233 ivalent guest molecules 4/5 cover the curved vesicular surface in a lateral fashion to satisfy the co

234 ur data demonstrate that FTY720 can activate vesicular synaptobrevin for SNARE complex formation and

235 amine neuron synapses, but also in mediating vesicular synergy, contributing to regional differences

236 tained suggest that the proposed transdermal vesicular system can serve as a promising alternative me

237 The transdermal vesicular system exhibited a significant decrease in pla

238 The vesicular systems were prepared by incorporating differe

239 for the production of nanoscale lipid-based vesicular systems.

240 ed in the synaptic terminal to small binding vesicular targets.

241 Hollow vesicular tissues of various sizes and shapes arise in b

242 branes transition among planar, budding, and vesicular topographies through nanoscale reorganization

243 The current model for vesicular traffic to and from the plasma membrane is acc

244 C and the small GTPase, Rab9, in alpha1B-AR vesicular traffic were investigated by studying alpha1B-

245 hospholipase D (PLD) is strongly involved in vesicular trafficking and cell signaling, making this en

246 These complexes limit intracellular vesicular trafficking and trap AMPARs inside the dendrit

247 R, alpha1 subunit of L-type VDCC, or various vesicular trafficking curators, including synaptotagmins

248 DPPA3 has a significant role in cytoplasmic vesicular trafficking in addition to its previously repo

249 in clathrin-dependent endocytosis and other vesicular trafficking processes by acting as a pair of m

250 TPase-activating function of GIT1 toward the vesicular trafficking regulator Arf6 GTPase is required

251 Golgi dispersal underlies the pro-metastatic vesicular trafficking that is associated with epithelial

252 shown to be required for optimal anterograde vesicular trafficking to the plasma membrane.

253 Abnormal vesicular trafficking was evidenced by delayed retrograd

254 culum stress) and Golgi apparatus, increased vesicular trafficking, and a depletion of mature beta-gr

255 upporting various cellular events, including vesicular trafficking, cell migration, and stereociliary

256 es for these two events in processes such as vesicular trafficking, DNA damage repair and RNA splicin

257 enes supporting involvement of intracellular vesicular trafficking, immune response and endo/lysosoma

258 Perturbations are observed in vesicular trafficking, lipid metabolism and in the endop

259 hering complex, a major coordinator of Golgi vesicular trafficking, thus remodeling Golgi membrane tr

260 osphate, a lipid that controls intracellular vesicular trafficking.

261 y for membrane fusion during eukaryotic cell vesicular trafficking.

262 gulating receptor-mediated signaling through vesicular trafficking.

263 se in insulin demand and/or a dysfunction in vesicular trafficking.

264 g their function in regulating intracellular vesicular trafficking.

265 l tight junctions or suppressing endothelial vesicular transcytosis.

266 tometry (VIEC) has been used to quantify the vesicular transmitter content in mammalian vesicles.

267 An unusually low rate of vesicular transport (transcytosis) has been identified a

268 reticulum remains functionally connected by vesicular transport after its fragmentation in cells exp

269 For applications such as the study of vesicular transport and drug delivery, there is a pressi

270 single particles and they cluster during the vesicular transport and maturation.

271 ontextual fear-conditioning and identify the vesicular transport and synaptogenesis pathways as the m

272 S-acylation/deacylation cycles and vesicular transport are critical for an adequate subcell

273 GN) is the sorting of proteins into distinct vesicular transport carriers that mediate secretion and

274 e important functions beyond their classical vesicular transport functions, including nutrient sensin

275 This dataset yields insights into how vesicular transport is adapted to the specialized functi

276 Non-vesicular transport is mediated by the interaction of me

277 bits the expression of key components of the vesicular transport machinery, and down-regulates Glutam

278 utophagy and lysosomal catabolism reflecting vesicular transport obstruction and defective lysosomal

279 the sphingolipid sphingomyelin requires non-vesicular transport of ceramide from the endoplasmic ret

280 Indeed, the vesicular transport of most classical transmitters invol

281 However, vesicular transport of the principal excitatory transmit

282 The SNARE-mediated vesicular transport pathway plays major roles in synapti

283 evealed that iRGD coadministration induced a vesicular transport pathway that carried Au-labeled sili

284 t least partly through the inhibition of the vesicular transport pathway.

285 ossess a pharmacopoeia of (1) the eukaryotic vesicular transport system, (2) immunity, and (3) previo

286 Incoming human papillomavirus (HPV) utilize vesicular transport to traffic from the plasma membrane

287 G (AnkG), a cytoskeletal protein involved in vesicular transport, as a novel aldosterone-induced prot

288 a mediator of endoplasmic reticulum to Golgi vesicular transport, at T75 to be regulated by TAK1 in v

289 ed that LTP-mediated lipid trafficking, like vesicular transport, can be subject to tight Ca(2+)regul

290 he apoplast) via transporters, channels, and vesicular transport.

291 metabolism of APP by altering its endocytic vesicular transport.

292 lgi localization of rab1a, a key mediator of vesicular transport.

293 mmobile complexes on microtubules that limit vesicular transport.

294 med are carried through the Golgi network by vesicular transport.

295 rons in the dorsal raphe nucleus, expressing vesicular transporters for GABA or glutamate (hereafter,

296 tion, dopamine vesicles utilize a cascade of vesicular transporters to dynamically increase the vesic

297 We measured VGLUT3-p.A211V activity by vesicular uptake in BON cells, electrophysiological reco

298 ne the relative importance of transcellular (vesicular) versus paracellular transport pathways by LEC

299 The vesicular zinc (Zn(2+)) transporter ZnT2 is critical for

300 ever, using knock-out animals (of MT-III and vesicular Zn(2+) transporter, ZnT3) and channel blockers